• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    CORE LAB REPORTS THIRD QUARTER 2024 RESULTS

    10/23/24 5:15:00 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy
    Get the next $CLB alert in real time by email
    • THIRD QUARTER REVENUE OF $134.4 MILLION, UP 3% SEQUENTIALLY AND OVER 7% YEAR-OVER-YEAR
    • THIRD QUARTER OPERATING INCOME OF $19.8 MILLION; EX-ITEMS, $18.2 MILLION, UP 11% SEQUENTIALLY AND 14% YEAR-OVER-YEAR
    • THIRD QUARTER OPERATING MARGINS, EX-ITEMS, OF 14% UP 100 BPS SEQUENTIALLY
    • THIRD QUARTER GAAP EPS OF $0.25; EX-ITEMS, $0.25, UP 14% SEQUENTIALLY AND YEAR-OVER-YEAR
    • THIRD QUARTER FREE CASH FLOW OF $10.4 MILLION
    • NET DEBT REDUCED BY $11.8 MILLION; DEBT LEVERAGE RATIO REDUCED TO 1.47
    • COMPANY ANNOUNCES Q4 2024 QUARTERLY DIVIDEND

    HOUSTON, Oct. 23, 2024 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported third quarter 2024 revenue of $134,400,000. Core's operating income was $19,800,000, with diluted earnings per share ("EPS") of $0.25, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $18,200,000, yielding operating margins of 14%, up 100 basis points sequentially, and EPS, ex-items, of $0.25. During the third quarter of 2024, the Company recorded an adjustment of $1,400,000 to stock compensation expense for certain performance share awards which are no longer expected to vest. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

    Core's CEO, Larry Bruno stated, "In the third quarter of 2024, Core Lab delivered solid sequential improvements in revenue, operating income, operating margins, incremental margins and earnings per share. Demand for our Reservoir Description services continued to grow across our international laboratory network despite headwinds from on-going geopolitical conflicts. In Production Enhancement, revenue increased sequentially, driven by higher international product sales. However, these improvements were somewhat offset by hurricane-related delays in diagnostic service revenue tied to suspended well operations in the Gulf of Mexico. Following positive meetings with Middle East operators in the second quarter of 2024, personal face-to-face meetings with Asia-Pacific operators during the third quarter reinforced growth opportunities for both of Core's operating segments. Collectively, these client meetings support our perspective for a multi-year cycle of expanded project activity. At the end of the third quarter, the Company achieved its longstanding goal of reducing our debt leverage ratio to below 1.50. The leverage ratio is now at its lowest level in over six years. Core remains focused on executing its strategic business initiatives while also reducing our debt leverage ratio, as the Company evaluates various opportunities to increase shareholder value."

    Reservoir Description

    Reservoir Description operations are closely correlated with trends in international and offshore activity levels, with approximately 80% of revenue sourced from projects originating outside the U.S. Revenue in the third quarter of 2024 was $88,800,000, up 3% sequentially and over 4% from last year. Operating income on a GAAP basis was $16,500,000, while operating income, ex-items, was $15,400,000, yielding operating margins of over 17%, a sequential improvement of 370 basis points. The segment's financial performance in the third quarter reflects growing demand for reservoir rock and fluid analysis across the Company's global operations. This growth occurred despite negative impacts from both on-going geopolitical conflicts, as well as disruption of work in the Gulf of Mexico due to weather events.

    Core Lab continues to expand its engagement in Carbon Capture and Sequestration ("CCS") projects, leveraging its expertise in reservoir characterization. In addition to Core's multi-company joint industry project that is being conducted in conjunction with Dr. Birol Dindoruk of the University of Houston, during the third quarter of 2024, the Company secured multiple contracts to evaluate CCS sites across the Gulf Coast region and other parts of the United States. Employing its proprietary laboratory reservoir characterization technologies, Core Lab is performing detailed petrophysical, geological and geochemical analyses, along with fluid flow experiments, formation damage assessments, and geomechanical testing. Core Lab's technologies are critical for evaluating the long-term viability of potential CO2 injection sites.

    Also, during the third quarter of 2024, engagement on projects in the Middle East continued to expand. Kuwait Oil Company ("KOC") selected Core Laboratories to lead a comprehensive fluid analysis campaign as part of an offshore exploration program in the Arabian Gulf. The project area is considered to have high potential for contributing to KOC's long-term production growth goals. High-quality pressure-volume-temperature ("PVT") analysis and advanced analytical chemistry are critical for evaluating reservoir maturity, volumetric potential, and production characteristics. The hard data points that Core Lab provides form the backbone of the reservoir models operators use to make major investment decisions.

    Production Enhancement

    Production Enhancement operations, which are focused on complex completions in unconventional oil and gas reservoirs in the U.S., as well as conventional and unconventional projects across the globe, posted third quarter 2024 revenue of $45,600,000, up 3% sequentially and over 13% year-over-year. Operating income on a GAAP basis was $3,200,000, while operating income, ex-items, was $2,600,000, yielding operating margins of 6%. The sequential financial performance reflects improvement in international product sales; however, this was offset by 1) a delay of diagnostic service revenue related to multiple hurricanes in the Gulf of Mexico and 2) to a lesser extent, a decline in U.S. land completion activity.

    In the third quarter of 2024, Core Lab's completion diagnostic technologies were utilized to provide insight into complex unconventional completions. For several years, operators in Alberta, Canada have been drilling and completing open-hole multilateral wells to optimize reservoir drainage. This wellbore architecture makes it difficult to confirm oil production from comingled laterals. Recently, an operator used Core's diagnostic technologies to determine if oil was being produced from individual laterals. To accomplish this, Core deployed its proprietary solid Flow Profiler OilTM technology, which placed a unique oil-activated tracer in each lateral. During initial production, fluid samples were collected at the surface and analyzed in the laboratory. The test results confirmed oil production from each lateral. Subsequently, the operator asked Core Lab to both confirm oil production from each lateral, and to identify the source(s) of produced water. The lab data from water tracers will provide the operator with the option to shut off boreholes with excessive water-production, thus reducing disposal costs. Core is currently preparing to deploy a family of newly developed solid water tracers that will also be placed in each lateral. By utilizing both oil and water tracers, the produced fluid samples will help the operator better understand how individual boreholes are contributing to comingled production.

    In 2023, a national oil company in the Middle East engaged Core's ballistic engineering team to develop a solution to improve operational efficiencies and reduce costs in offshore plug and abandonment ("P&A") well operations. Leveraging its expertise in energetics as an alternative to traditional casing section milling, Core developed an innovative technology to accelerate P&A operations. During the third quarter of 2024, the Company's ballistic engineering design team deployed its patented Pulverizor™ technology. The Pulverizor™ technology: 1) rubbilizes the cement, 2) generates a significant level of cement debonding with the target casing interval, and 3) allows the casing to be pulled to the surface without having to wash the annulus. Field trials successfully demonstrated that PulverizorTM reduced the amount of rig overpull required to retrieve casing without having to conduct the wash operation. Pulverizor™ not only contributes to the safety of offshore well abandonment, but also aligns with increasing global demand for cost-effective solutions in complex P&A applications. Core Lab is presenting this new technology as a co-author and co-presenter at ADIPEC in November of this year.

    Liquidity, Free Cash Flow and Dividend

    Core continues to focus on maximizing free cash flow ("FCF"), a non-GAAP financial measure defined as cash from operations less capital expenditures. For the third quarter of 2024, cash from operations was $13,100,000 and capital expenditures were $2,700,000, yielding FCF of $10,400,000. The Company generated $27,100,000 of FCF for the nine months ended September 30, 2024, a significant improvement from the same period last year. The year-over-year improvement in FCF generated during 2024 reflects higher profitability, as well as better management of inventory and working capital.

    Core expects to continue generating positive free cash flow in future quarters. As of September 30, 2024, Core's net debt (defined as long-term debt less cash and cash equivalents) was $120,500,000, which was reduced by $11,800,000 during the quarter. The Company's leverage ratio (calculated as total net debt divided by adjusted EBITDA for the last four quarters) was reduced to 1.47 as of September 30, 2024, which improved from 1.66 as of June 30, 2024. Core will remain focused on executing its strategic business initiatives while also further reducing our debt leverage ratio as the Company continues to evaluate allocation of capital and other uses of free cash.

    On July 24, 2024, Core's Board of Directors ("Board") announced a quarterly cash dividend of $0.01 per share of common stock, which was paid on August 26, 2024 to shareholders of record on August 5, 2024.

    On October 23, 2024, the Board approved a cash dividend of $0.01 per share of common stock payable on November 25, 2024 to shareholders of record on November 4, 2024.  

    Return On Invested Capital

    The Board and the Company's Executive Management continue to focus on strategies that maximize return on invested capital ("ROIC") and FCF, factors that have high correlation to total shareholder return. Core's commitment to an asset-light business model and disciplined capital stewardship promotes capital efficiency and are designed to produce more predictable and superior long-term ROIC.

    The Board has established an internal metric to demonstrate ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg, as the Company continues to believe superior ROIC will result in higher total shareholder return. Using Bloomberg's formula, the Company's ROIC as of September 30, 2024 was 8.6%.

    Industry and Core Lab Outlook and Guidance

    Core Lab continues to see a multi-year international recovery due to underinvestment, increasing focus on energy security and rising crude-oil demand, all supporting continued activity growth into 2025. In alignment with this outlook, Core will continue to execute its strategic plan of investing in technology and pursuing growth opportunities, while remaining well-engaged on long-cycle international projects. The IEA, EIA and OPEC+ continue to forecast growth in crude-oil demand between 1.0 and 1.6 million barrels per day for 2025, which is in addition to the natural decline of production from existing fields. As such, continued investment in the development of onshore and offshore crude-oil fields will be required to meet the projected growth in demand. In the near-term, we expect that crude-oil markets will remain volatile due to global economic and geopolitical risks and uncertainties.

    Consequently, as international project activity continues to expand, committed long-term upstream projects from the Middle East, South Atlantic Margin, certain areas of Asia Pacific and West Africa support year-over-year growth in demand for Core Lab's services and products. Core anticipates U.S. land activity to trend lower in the fourth quarter of 2024, however, return to similar activity levels year-over-year in 2025. For the near-term, U.S. land activity is currently negatively influenced by recent E&P consolidations and weak natural gas prices. 

    Fourth quarter 2024 guidance for both business segments includes the impact of client project delays caused by weather events in the Gulf of Mexico. Core projects Reservoir Description's fourth quarter 2024 revenue to be flat to up slightly. Turning to Production Enhancement, the U.S. frac spread count continues to trend lower. In addition, the Company anticipates the typical year-end seasonal decline in U.S. onshore completion activity. 

    Reservoir Description's fourth quarter 2024 revenue is projected to range from $87,500,000 to $90,500,000, with operating income of $13,400,000 to $14,900,000. Core's Production Enhancement segment's fourth quarter 2024 revenue is estimated to range from $41,000,000 to $45,000,000, with operating income of $1,300,000 to $2,700,000. 

    The Company's fourth quarter 2024 revenue is projected to range from $128,500,000 to $135,500,000, with operating income of $14,800,000 to $17,700,000, yielding operating margins of approximately 12%. EPS for the fourth quarter of 2024 is expected to be $0.20 to $0.25.    

    The Company's fourth quarter 2024 guidance is based on projections for underlying operations and excludes gains and losses in foreign exchange. Fourth quarter 2024 guidance also assumes an effective tax rate of 20%.

    Earnings Call Scheduled

    The Company has scheduled a conference call to discuss Core's third quarter 2024 earnings announcement. The call will begin at 7:30 a.m. CDT / 8:30 a.m. EDT on Thursday, October 24, 2024.  To listen to the call, please go to Core's website at www.corelab.com.

    Core Laboratories Inc. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world. This release, as well as other statements we make, includes forward-looking statements regarding the Company's future revenue, profitability, business strategies and developments, demand for the Company's products and services and for products and services of the oil and gas industry generally, made in reliance upon the safe harbor provisions of Federal securities law. The Company's outlook is subject to various important cautionary factors, including risks and uncertainties related to the oil and natural gas industry, business and general economic conditions, including inflationary pressures, the ability to achieve the benefits of the redomestication of the parent company from the Netherlands to the United States, international markets, international political climates, including the Russia-Ukraine and the Middle East geopolitical conflicts, public health crises, and any related actions taken by businesses and governments, and other factors as more fully described in the Company's most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. These important factors could cause the Company's actual results to differ materially from those described in these forward-looking statements. Such statements are based on current expectations of the Company's performance and are subject to a variety of factors, some of which are not under the control of the Company. Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company's future performance.

    The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.

    Visit the Company's website at www.corelab.com. Connect with Core Lab on Facebook, LinkedIn and YouTube.

     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share data)

    (Unaudited)







    Three Months Ended





    % Variance





    September 30,

    2024





    June 30,

    2024





    September 30,

    2023





    vs. Q2-24



    vs. Q3-23

    REVENUE



    $

    134,397





    $

    130,577





    $

    125,343





    2.9 %



    7.2 %





























    OPERATING EXPENSES:



























    Costs of services and product sales





    106,805







    102,930







    96,617





    3.8 %



    10.5 %

    General and administrative expense





    8,642







    10,259







    9,452





    (15.8) %



    (8.6) %

    Depreciation and amortization





    3,676







    3,770







    3,929





    (2.5) %



    (6.4) %

    Other (income) expense, net





    (4,529)







    (2,390)







    673





    NM



    NM

    Total operating expenses





    114,594







    114,569







    110,671





    — %



    3.5 %





























    OPERATING INCOME





    19,803







    16,008







    14,672





    23.7 %



    35.0 %

    Interest expense





    3,108







    3,209







    3,147





    (3.1) %



    (1.2) %

    Income before income taxes





    16,695







    12,799







    11,525





    30.4 %



    44.9 %

    Income tax expense





    4,691







    3,609







    2,305





    30.0 %



    103.5 %

    Net income





    12,004







    9,190







    9,220





    30.6 %



    30.2 %

    Net income (loss) attributable to non-controlling interest





    259







    158







    (37)





    NM



    NM

    Net income attributable to Core Laboratories Inc.



    $

    11,745





    $

    9,032





    $

    9,257





    30.0 %



    26.9 %





























    Diluted earnings per share



    $

    0.25





    $

    0.19





    $

    0.19





    31.6 %



    31.6 %





























    Diluted earnings per share attributable to Core Laboratories Inc.



    $

    0.25





    $

    0.19





    $

    0.19





    31.6 %



    31.6 %





























    Diluted weighted average common shares outstanding





    47,820







    47,743







    47,604





    0.2 %



    0.5 %





























    Effective tax rate





    28

    %





    28

    %





    20

    %



    NM



    NM





























    SEGMENT INFORMATION:























































    Revenue:



























    Reservoir Description



    $

    88,840





    $

    86,277





    $

    85,145





    3.0 %



    4.3 %

    Production Enhancement





    45,557







    44,300







    40,198





    2.8 %



    13.3 %

    Consolidated



    $

    134,397





    $

    130,577





    $

    125,343





    2.9 %



    7.2 %





























    Operating income:



























    Reservoir Description



    $

    16,487





    $

    11,443





    $

    12,992





    44.1 %



    26.9 %

    Production Enhancement





    3,232







    4,401







    1,544





    (26.6) %



    109.3 %

    Corporate and Other





    84







    164







    136





    NM



    NM

    Consolidated



    $

    19,803





    $

    16,008





    $

    14,672





    23.7 %



    35.0 %





























    "NM" means not meaningful



























     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share data)

    (Unaudited)







    Nine Months Ended

    September 30,





    % Variance





    2024





    2023







    REVENUE



    $

    394,611





    $

    381,580





    3.4 %



















    OPERATING EXPENSES:

















    Costs of services and product sales





    314,323







    298,440





    5.3 %

    General and administrative expense





    30,690







    31,594





    (2.9) %

    Depreciation and amortization





    11,289







    11,910





    (5.2) %

    Other (income) expense, net





    (6,073)







    (423)





    NM

    Total operating expenses





    350,229







    341,521





    2.5 %



















    OPERATING INCOME





    44,382







    40,059





    10.8 %

    Interest expense





    9,740







    9,812





    (0.7) %

    Income before income taxes





    34,642







    30,247





    14.5 %

    Income tax expense (benefit)





    9,958







    (4,344)





    NM

    Net income





    24,684







    34,591





    (28.6) %

    Net income attributable to non-controlling interest





    687







    115





    NM

    Net income attributable to Core Laboratories Inc.



    $

    23,997





    $

    34,476





    (30.4) %



















    Diluted earnings per share



    $

    0.52





    $

    0.73





    (28.8) %



















    Diluted earnings per share attributable to Core Laboratories Inc.



    $

    0.50





    $

    0.73





    (31.5) %



















    Diluted weighted average common shares outstanding





    47,690







    47,536





    0.3 %



















    Effective tax rate





    29

    %





    (14)

    %



    NM



















    SEGMENT INFORMATION:



































    Revenue:

















    Reservoir Description



    $

    259,353





    $

    248,717





    4.3 %

    Production Enhancement





    135,258







    132,863





    1.8 %

    Consolidated



    $

    394,611





    $

    381,580





    3.4 %



















    Operating income:

















    Reservoir Description



    $

    34,823





    $

    28,780





    21.0 %

    Production Enhancement





    9,209







    10,324





    (10.8) %

    Corporate and Other





    350







    955





    NM

    Consolidated



    $

    44,382





    $

    40,059





    10.8 %





































    "NM" means not meaningful

















     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands)

    (Unaudited) 

























    % Variance

    ASSETS:



    September 30,

    2024





    June 30,

    2024





    December 31,

    2023





    vs. Q2-24



    vs. Q4-23





























    Cash and cash equivalents



    $

    21,474





    $

    17,695





    $

    15,120





    21.4 %



    42.0 %

    Accounts receivable, net





    117,591







    115,644







    109,352





    1.7 %



    7.5 %

    Inventories





    65,490







    69,898







    71,702





    (6.3) %



    (8.7) %

    Other current assets





    30,672







    30,291







    26,962





    1.3 %



    13.8 %

    Total current assets





    235,227







    233,528







    223,136





    0.7 %



    5.4 %





























    Property, plant and equipment, net





    97,606







    98,510







    99,626





    (0.9) %



    (2.0) %

    Right of use assets





    56,650







    55,689







    53,842





    1.7 %



    5.2 %

    Intangibles, goodwill and other long-term assets, net





    210,983







    210,072







    209,791





    0.4 %



    0.6 %

    Total assets



    $

    600,466





    $

    597,799





    $

    586,395





    0.4 %



    2.4 %





























    LIABILITIES AND EQUITY:























































    Accounts payable



    $

    33,627





    $

    36,863





    $

    33,506





    (8.8) %



    0.4 %

    Short-term operating lease liabilities





    11,435







    11,045







    10,175





    3.5 %



    12.4 %

    Other current liabilities





    49,876







    49,690







    44,416





    0.4 %



    12.3 %

    Total current liabilities





    94,938







    97,598







    88,097





    (2.7) %



    7.8 %





























    Long-term debt, net





    139,872







    147,621







    163,134





    (5.2) %



    (14.3) %

    Long-term operating lease liabilities





    43,727







    42,616







    42,076





    2.6 %



    3.9 %

    Other long-term liabilities





    65,508







    64,270







    63,281





    1.9 %



    3.5 %





























    Total equity





    256,421







    245,694







    229,807





    4.4 %



    11.6 %

    Total liabilities and equity



    $

    600,466





    $

    597,799





    $

    586,395





    0.4 %



    2.4 %

     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)









    Nine Months Ended September 30,







    2024





    2023



    CASH FLOWS FROM OPERATING ACTIVITIES:













    Net income



    $

    24,684





    $

    34,591



    Adjustments to reconcile net income to net cash provided by operating activities:













    Stock-based compensation





    4,213







    12,406



    Depreciation and amortization





    11,289







    11,910



    Deferred income taxes





    102







    (14,757)



    Accounts receivable





    (9,461)







    2,872



    Inventories





    6,212







    (14,614)



    Accounts payable





    (373)







    (13,101)



    Other adjustments to net income





    (893)







    (13,947)



    Net cash provided by operating activities





    35,773







    5,360

















    CASH FLOWS FROM INVESTING ACTIVITIES:













    Capital expenditures





    (8,647)







    (7,843)



    Net proceeds on life insurance policies and from insurance recovery





    4,878







    3,375



    Other investing activities





    934







    262



    Net cash used in investing activities





    (2,835)







    (4,206)

















    CASH FLOWS FROM FINANCING ACTIVITIES:













    Repayment of long-term debt





    (62,000)







    (184,000)



    Proceeds from long-term debt





    38,000







    190,000



    Debt issuance cost





    —







    (1,251)



    Dividends paid





    (1,407)







    (1,401)



    Repurchase of common shares





    (402)







    (418)



    Equity related transaction costs





    (756)







    (2,842)



    Other financing activities





    (19)







    (54)



    Net cash provided by (used in) financing activities





    (26,584)







    34

















    NET CHANGE IN CASH AND CASH EQUIVALENTS





    6,354







    1,188



    CASH AND CASH EQUIVALENTS, beginning of period





    15,120







    15,428



    CASH AND CASH EQUIVALENTS, end of period



    $

    21,474





    $

    16,616



     

    Non-GAAP Information

    Management believes that the exclusion of certain income and expenses enables it to evaluate more effectively the Company's operations period-over-period and to identify operating trends that could otherwise be masked by the excluded Items. For this reason, management uses certain non-GAAP measures that exclude these Items and believes that this presentation provides a clearer comparison with the results reported in prior periods. The non-GAAP financial measures should be considered in addition to, and not as a substitute for, the financial results prepared in accordance with GAAP, as more fully discussed in the Company's financial statements and filings with the Securities and Exchange Commission.

     

    Reconciliation of Operating Income, Net Income and Diluted Earnings Per Share Attributable to Core Laboratories Inc.

    (In thousands, except per share data)

    (Unaudited)







    Operating Income







    Three Months Ended







    September 30,

    2024





    June 30,

    2024





    September 30,

    2023



    GAAP reported



    $

    19,803





    $

    16,008





    $

    14,672



    Stock compensation (1)





    (1,364)







    —







    —



    Loss on lease abandonment and assets write-down (2)





    —







    —







    633



    ATM termination costs (3)





    —







    —







    455



    Foreign exchange losses (gains)





    (239)







    388







    238



    Excluding specific items



    $

    18,200





    $

    16,396





    $

    15,998











    Net Income Attributable to Core Laboratories Inc.







    Three Months Ended







    September 30,

    2024





    June 30,

    2024





    September 30,

    2023



    GAAP reported



    $

    11,745





    $

    9,032





    $

    9,257



    Stock compensation (1)





    (1,091)







    —







    —



    Loss on lease abandonment and assets write-down (2)





    —







    —







    505



    ATM termination costs (3)





    —







    —







    364



    Foreign exchange losses (gains)





    (191)







    310







    190



    Effect of higher (lower) tax rate (4)





    1,351







    1,050







    —



    Excluding specific items



    $

    11,814





    $

    10,392





    $

    10,316











    Diluted Earnings Per Share Attributable to Core Laboratories Inc.







    Three Months Ended







    September 30,

    2024





    June 30,

    2024





    September 30,

    2023



    GAAP reported



    $

    0.25





    $

    0.19





    $

    0.19



    Stock compensation (1)





    (0.02)







    —







    —



    Loss on lease abandonment and assets write-down (2)





    —







    —







    0.01



    ATM termination costs (3)





    —







    —







    0.01



    Foreign exchange losses (gains)





    (0.01)







    0.01







    0.01



    Effect of higher (lower) tax rate (4)





    0.03







    0.02







    —



    Excluding specific items



    $

    0.25





    $

    0.22





    $

    0.22























    (1) Three months ended September 30, 2024 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share awards.

    (2) Three months ended September 30, 2023 includes the write-down of leasehold improvements, right of use assets and/or other assets and exit costs associated with consolidation of certain facilities.

    (3) Three months ended September 30, 2023 includes the write off of previously deferred costs upon termination of our "at-the-market offering" ("ATM") Program.

    (4) Three months ended September 30, 2024 and June 30, 2024 includes the effect to reflect tax expense at a normalized rate of 20%.

     

    Segment Information

    (In thousands)

    (Unaudited)







    Operating Income







    Three Months Ended September 30, 2024







    Reservoir

    Description





    Production

    Enhancement





    Corporate and

    Other



    GAAP reported



    $

    16,487





    $

    3,232





    $

    84



    Stock compensation





    (881)







    (483)







    —



    Foreign exchange losses (gains)





    (157)







    (117)







    35



    Excluding specific items



    $

    15,449





    $

    2,632





    $

    119



     

    Return on Invested Capital

    Return on Invested Capital ("ROIC") is presented based on management's belief that this non-GAAP measure is useful information to investors and management when comparing profitability and the efficiency with which capital has been employed over time relative to other companies. The Board has established an internal metric to demonstrate ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg. ROIC is not a measure of financial performance under GAAP and should not be considered as an alternative to net income.

    ROIC of 8.6% is defined by Bloomberg as Net Operating Profit After Tax ("NOPAT") of $34.9 million divided by Average Total Invested Capital ("Average TIC") of $407.6 million where, NOPAT is defined as GAAP net income before non-controlling interest plus the sum of income tax expense, interest expense, and pension expense less pension service cost and tax effect on income before interest and tax expense for the last four quarters. Average TIC is defined as the average of beginning and ending periods' GAAP stockholders' equity plus the sum of net long-term debt, lease liabilities, allowance for credit losses, net of deferred taxes, and income taxes payable.

    Free Cash Flow

    Core uses the non-GAAP financial measure of free cash flow to evaluate its cash flows and results of operations. Free cash flow is defined as net cash provided by operating activities (which is the most directly comparable GAAP measure) less cash paid for capital expenditures. Management believes that free cash flow provides useful information to investors regarding the cash available in the period that was in excess of Core's needs to fund its capital expenditures and operating activities. Free cash flow is not a measure of operating performance under GAAP and should not be considered in isolation nor construed as an alternative to operating income, net income, or cash flows from operating, investing, or financing activities, each as determined in accordance with GAAP. Free cash does not represent residual cash available for distribution because Core may have other non-discretionary expenditures that are not deducted from the measure. Moreover, since free cash flow is not a measure determined in accordance with GAAP and thus is susceptible to varying interpretations and calculations, free cash flow as presented may not be comparable to similarly titled measures presented by other companies.

    Computation of Free Cash Flow

    (In thousands)

    (Unaudited)







    Three Months Ended





    Nine Months Ended









    September 30, 2024





    September 30, 2024





    Net cash provided by operating activities



    $

    13,097





    $

    35,773





    Capital expenditures





    (2,729)







    (8,647)





    Free cash flow



    $

    10,368





    $

    27,126





     

    Core Laboratories logo (PRNewsFoto/Core Laboratories) (PRNewsfoto/Core Laboratories)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/core-lab-reports-third-quarter-2024-results-302285122.html

    SOURCE Core Laboratories Inc

    Get the next $CLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLB

    DatePrice TargetRatingAnalyst
    3/12/2025$15.00 → $16.00Sell → Neutral
    Citigroup
    6/30/2023$22.00 → $21.00Neutral → Sell
    Citigroup
    4/18/2023$21.50Neutral → Underperform
    BofA Securities
    1/9/2023Underperform → Neutral
    BofA Securities
    10/7/2022$24.00 → $17.00Sell → Neutral
    Citigroup
    9/26/2022$20.00Equal-Weight → Underweight
    Morgan Stanley
    4/18/2022$19.50 → $21.30Neutral → Underweight
    Piper Sandler
    1/18/2022$32.00 → $30.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $CLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CORE LABORATORIES ANNOUNCES OPENING OF UNCONVENTIONAL CORE ANALYSIS LABORATORY IN SAUDI ARABIA

      HOUSTON, May 7, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory in Dammam, Kingdom of Saudi Arabia. This state-of-the-art facility, developed in collaboration with Core's long-time partner, Abdulla Fouad Group, underscores the Company's commitment to advancing reservoir evaluation technologies in the Middle East. The Company's new analytical laboratory is equipped with advanced proprietary instrumentation designed to provide comprehensive core and fluid analysis services tailored to unconventional reservoirs. By bringing Core Lab's cutting-edge technologies t

      5/7/25 12:53:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

      REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAROPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEARFREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,6

      4/23/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

      HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

      3/24/25 4:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Financials

    Live finance-specific insights

    See more
    • CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

      REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAROPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEARFREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,6

      4/23/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

      HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

      3/24/25 4:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

      FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEARFOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDENDFULL YEAR REVENUE OF $523.8 MILLION, UP 3%FULL

      1/29/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 79 shares and converted options into 175 shares (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      5/5/25 2:55:21 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 178 shares and converted options into 450 shares, decreasing direct ownership by 1% to 16,072 units (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      5/5/25 2:53:25 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Director Temeng Kwaku converted options into 9,317 shares, increasing direct ownership by 57% to 25,528 units (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      4/2/25 2:40:47 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Core Labs upgraded by Citigroup with a new price target

      Citigroup upgraded Core Labs from Sell to Neutral and set a new price target of $16.00 from $15.00 previously

      3/12/25 7:22:24 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Labs downgraded by Citigroup with a new price target

      Citigroup downgraded Core Labs from Neutral to Sell and set a new price target of $21.00 from $22.00 previously

      6/30/23 7:19:53 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Labs downgraded by BofA Securities with a new price target

      BofA Securities downgraded Core Labs from Neutral to Underperform and set a new price target of $21.50

      4/18/23 9:05:50 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Core Laboratories Inc. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      6/12/23 4:02:30 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      2/14/23 4:08:12 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      2/14/23 9:10:51 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    SEC Filings

    See more
    • SEC Form 10-Q filed by Core Laboratories Inc.

      10-Q - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      4/25/25 6:36:23 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      4/23/25 4:41:18 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form DEFA14A filed by Core Laboratories Inc.

      DEFA14A - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      3/31/25 4:59:20 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy